Clinical Trials Logo

Clinical Trial Summary

This study proposes to introduce an outpatient Occupational Therapy (OT)-led diabetes intervention program. OTs with training in diabetes self-management modules that address physical, social, emotional, and systemic factors that influence health. Patients receiving outpatient OT services for development of diabetes self-management skills will be seen for approximately 8 forty five-minute to one-hour sessions over 6 months. OTs will communicate with other interdisciplinary care team members using Electronic Health Record (EHR) messaging, phone calls, and in-person communication as needed. There will be at minimum a monthly consult meeting with a doctor of psychology (Psy D), registered dietitian (RD), social worker (SW), and pharmacist (PharmD), and the primary care medical team will be provided with monthly progress notes. The investigators hypothesize that participants demonstrate improved blood sugar levels, improved ability to take medications as directed, increases in overall sense of physical, mental, and social health, and positive changes in their self-efficacy related to diabetes self-management. The investigators also hypothesize that OT visits will be reimbursed by insurers more than 50% of all billed visits.


Clinical Trial Description

Effective interventions to support patients' diabetes management are urgently needed to curtail the growing financial and human cost of diabetes. However, sustainable solutions to this health challenge have been elusive due to the intrinsic and extrinsic barriers patients face when attempting to incorporate necessary health behaviors into their daily routines (e.g., dietary changes, physical activity, medication management, blood glucose monitoring, and stress management). The focus of occupational therapy (OT) is to work with patients within the context of their daily lives. OTs identify current patient roles (work, family, community), habits, and routines, then work with the patient to identify and address barriers to diabetes self-management within these aspects of their daily lives. Within OT, an intervention approach informed by Lifestyle Redesign (LR) has been shown to be effective at improving diabetes-related health outcomes among people with diabetes. This study proposes to introduce an OT- led diabetes intervention program into an outpatient OT clinic. The intervention is an interdisciplinary team approach as the intervention is informed and monitored by the interdisciplinary team members, who are part of the planning process, and who will participate in regular review of the intervention and the patient needs. With OT leading the team to address barriers to lifestyle modification, the primary care medical team will continue to oversee the overall health care of the patient. The OT will communicate regularly with the primary care team.

OTs with training in diabetes education will deliver the intervention to patients in the study within the course of their typical work day at the OT clinic. Treatment activities and materials will be delivered in English or Spanish, per patient preference as one of the OT interventionists is fluent in Spanish. Patients receiving OT services for development of diabetes self-management skills will be seen for approximately 8 forty five-minute to one-hour sessions over 6 months. OT notes will be maintained within the Electronic Health Record (EHR) as is standard practice at this clinic; the therapist will communicate with other interdisciplinary care team members using EHR messaging, phone calls, and in-person communication as needed. There will be at minimum a monthly consult meeting with a doctor of psychology (Psy D), registered dietitian (RD), social worker (SW), and pharmacist (PharmD), and the primary care medical team will be provided with monthly progress notes.

The intervention will be offered in a one-on-one direct therapy format. The intervention will focus on lifestyle modification strategies that will improve the patient's diabetes self-management skills. The intervention is organized into five modules that address:

- living with diabetes,

- strategies to communicate with healthcare providers to ensure patient needs are met,

- analyzing and modifying patient habits and routines to determine what changes they must make to manage their diabetes,

- identify and use social supports to help manage diabetes

- strategies to reduce stress and depression, improve emotional well-being, and minimize risk of diabetes burn-out (patient frustration with living with the disease)

Each patient receives an individually tailored combination of modules, and treatment activities within each module as established through collaborative goal setting between the patient and OT during the initial evaluation.

The investigators will analyze outcomes using descriptive analytics and paired t-tests to test our hypotheses. The investigators will collect EHR data on HbA1c and compare pre/post measures of the clinically relevant self-report surveys on diabetes self care, and barriers to self-care and management (Diabetes Empowerment Scale, Medication Adherence Assessment Scale, and the Canadian Occupational Performance Measure), physical, mental, and social health (Patient-Reported Outcomes Measurement Information System® PROMIS-29). Changes in HbA1c levels will be tracked by obtaining recent levels from the patient's primary care team. With patients referred to the OT intervention who have not had an HbA1c within ≤4 weeks of the initial referral date, the OT will consult with the primary care physician and determine if an HbA1c level can be obtained as a part of their normal care. The investigators will collect EHR data on follow-up HbA1c testing scores that are available within 12 weeks of the 8th OT visit and self-report surveys the day of 8th OT visit. If a patient has completed the full intervention, the study staff will follow-up biweekly for no more than 3 months after their initial visit, and attempt to collect self-report data up to 6 months after the final visit to determine the sustainability of outcomes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03821662
Study type Interventional
Source Arizona State University
Contact
Status Completed
Phase N/A
Start date April 11, 2019
Completion date July 30, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2